Gastrointestinal Stromal Tumor Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Gastrointestinal Stromal Tumor stocks.

Gastrointestinal Stromal Tumor Stocks Recent News

Date Stock Title
May 3 BPMC Blueprint Medicines Corporation (NASDAQ:BPMC) Q1 2024 Earnings Call Transcript
May 3 BPMC Blueprint (BPMC) Q1 Earnings and Revenues Beat, Stock Rises
May 3 DCPH The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
May 3 BPMC Blueprint Medicines Corp (BPMC) (Q1 2024) Earnings Call Transcript Highlights: Surpassing ...
May 3 BPMC Q1 2024 Blueprint Medicines Corp Earnings Call
May 2 BPMC Blueprint Medicines Corporation (BPMC) Q1 2024 Earnings Call Transcript
May 2 BPMC Blueprint Medicines Corporation 2024 Q1 - Results - Earnings Call Presentation
May 2 DCPH Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
May 2 BPMC Blueprint Medicines Corp Reports Q1 2024 Earnings, Surpasses Revenue Estimates and Raises ...
May 2 BPMC Blueprint Medicines (BPMC) Reports Q1 Loss, Tops Revenue Estimates
May 2 BPMC Blueprint Medicines  GAAP EPS of $1.40 beats by $3.05, revenue of $96.12M beats by $14.68M
May 2 BPMC Blueprint Medicines Reports Strong First Quarter 2024 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full Year Revenue Guidance
May 1 BPMC Blueprint Medicines Q1 2024 Earnings Preview
Apr 30 BPMC Will Apellis Pharmaceuticals, Inc. (APLS) Report Negative Earnings Next Week? What You Should Know
Apr 30 DCPH ONO to acquire Deciphera Pharmaceuticals in $2.4B deal
Apr 30 DCPH Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion
Apr 29 DCPH Why Is Cancer Focused Deciphera Pharmaceuticals Stock Skyrocketing On Monday?
Apr 29 DCPH Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Apr 29 DCPH Ono Pharmaceutical acquires cancer-focused biopharma Deciphera for $2.4bn
Apr 29 DCPH Deciphera Agrees to $2.4 Billion Buyout Offer From Japan's ONO Pharmaceutical
Gastrointestinal Stromal Tumor

Gastrointestinal stromal tumor (GIST) is a type of cancer that develops in the digestive tract. It is a rare type of cancer that affects the cells of the digestive tract, most commonly the stomach and small intestine. GISTs can be benign (non-cancerous) or malignant (cancerous). Symptoms of GIST can include abdominal pain, nausea, vomiting, and weight loss. Treatment for GIST typically involves surgery to remove the tumor, as well as chemotherapy and/or radiation therapy.

Browse All Tags